Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose ATG Conditioning for sUCBT in Aplastic Anemia
NCT07885982Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Aug 2027
- Primary completion
- Apr 2029
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit in aplastic anemia, sponsored by The First Affiliated Hospital of USTC. Planned start Aug 2027; status: not yet recruiting.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT07885982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07885982.